Compensated Liver Disease (Disorder) research hub
3 indexed studies · 1 currently recruiting
- active not recruitingNA
Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection
This study looks for ways to tell which patients with Hepatitis D can safely stop a treatment called Bulevirtide without their infection coming back. We want to find signs (biomarkers) that show who can stop treatment and stay well.
Germany · Italy - recruitingPHASE1
Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection
This study is testing a new antibody, HepB mAb19, for people with chronic hepatitis D (HDV). HDV needs hepatitis B (HBV) to survive. Researchers hope this antibody, by reducing HBV, will also help treat HDV. It's a small, early-stage study to check safety and how well it works.
Denmark · Germany - active not recruitingPHASE2
SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.
This study looks at new drug combinations (VIR-2218 and VIR-3434) to treat long-lasting Hepatitis D infection. It's a Phase 2 trial, meaning researchers are checking if these treatments are safe, handleable, and work well in people.
Bulgaria · France · Germany